The preferred way of initiating insulin in people with type 2 diabetes is to add basal insulin to the existing pharmacological therapy, in conjunction with revisiting health behaviours and re-referral to DSMES
The slow intravenous infusion protocols used in clinical trials minimized these effects, suggesting that rapid bolus administration (which is essentially what subcutaneous injection creates) may increase the likelihood of transient side effects
Como cada parte del cuerpo el cerebro, la piel, el intestino y otros rganos se ve afectada por el estrs oxidativo, el glutatin resulta beneficioso de forma global
J Nutr 129:S227S237 Lecker SH, Solomon V, Price SR, Kwon YT, Mitch WE, Goldberg AL (1999) Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats
Heres the data on what changed, why, and what legitimate options remain